Tag: Cancer: Laryngeal
High-Dose Hypofractionated RT Palliative in Head, Neck Cancer
Meaningful palliative effect for 63 percent of patients, lasting for median of 4.6 months
No Specific Findings to ID Recurrence in Head and Neck CA
No definite index of symptoms or signs indicating local recurrence, second primary malignancy
H. pylori Linked to Increased Odds of Laryngeal Carcinoma
Review shows significantly increased odds of laryngeal carcinoma but not pharyngeal cancer
Metformin Linked to Lower Risk of Head, Neck Cancer
Diabetes patients treated with the drug less likely to develop oropharyngeal, nasopharyngeal cancers
Veterans Have Poor Oral, Throat Cancer Outcomes
In oropharyngeal squamous cell carcinoma, overall survival at five years is 40 percent
Blood, Saliva Tests May Help ID Head and Neck Cancers Early
Study shows potential for noninvasive tumor detection
Meta-Analysis: Oral Sex Is Not Risk Factor for Oral Cancer
Analysis shows no significant correlation between oral sex and oral cancer risk
Full Adherence to Follow-Up Improves Head/Neck CA Survival
Survival more likely with compliance with posttreatment surveillance, tobacco cessation
HPV4 Vaccine Cost-Effective for OPC Prevention in Teen Boys
Quadrivalent vaccine appears cost-effective among 12-year-old boys in Canada
Many Head and Neck Cancer Survivors Don’t Return to Work
Current unemployment linked to harder physical work, surgical treatment, risky alcohol consumption
